A dye to check ureter patency in pediatric surgery
Treatments studied
Part of Kidney & urinary clinical trials.
This study tests a dye that helps surgeons see if the ureters are open during urological or gynecological surgery. It may lower the risk of accidentally injuring the ureters.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Patients from birth up to just before their 17th birthday.
- Parent or legal guardian must sign a consent form (and the child, if old enough, must agree to participate).
- Scheduled for a urological or gynecological surgery where the surgeon needs to check that the ureters (tubes from kidney to bladder) are open.
- Cannot have severe kidney failure or (if under 1 year) very high creatinine levels.
- Must weigh at least 5 kg (about 11 pounds).
- No known severe allergic reactions to the study dye or similar contrast agents.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a blue dye (Indigotindisulfonate Sodium) given during surgery to help doctors see if the tube from your kidney to bladder (ureter) is open. It's for people who are already having a surgery where that check is needed.
This trial tests a blue dye (Bludigo) to help doctors see if the ureters are open during surgery. It is for people with normal or reduced kidney function who need a procedure where the ureters are checked.
This trial tests an injection called IS-001 during robotic-assisted colorectal surgery. It may help surgeons see the ureters more clearly, which could reduce the risk of injury.
This trial tests a dye called Nizaracianine Triflutate that helps surgeons see the ureters (tubes from kidneys to bladder) during surgery. It aims to make surgery safer by reducing the risk of accidentally injuring the ureters.
This study tests a tiny amount of a dye called Indocyanine Green (ICG) during surgery to see if it safely shows blood flow to the gut and urinary organs. It may help doctors check that these organs are getting enough blood during the operation.
This trial studies whether a device called Dye-Vert Plus can lower the risk of kidney injury from contrast dye during heart catheter procedures (CAG and/or PCI). It focuses on people at higher kidney risk, especially those with diabetes or high blood pressure.
Hear when a new Ureter Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.